nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—hypertension—obesity	0.438	1	CtDrD
Nebivolol—ADRB1—obesity	0.135	0.543	CbGaD
Nebivolol—ADRB2—obesity	0.114	0.457	CbGaD
Nebivolol—ADRB2—Phenylpropanolamine—obesity	0.077	0.352	CbGbCtD
Nebivolol—ADRB1—Phenylpropanolamine—obesity	0.0758	0.346	CbGbCtD
Nebivolol—CYP2D6—Phentermine—obesity	0.0202	0.0924	CbGbCtD
Nebivolol—CYP2D6—Bupropion—obesity	0.0172	0.0786	CbGbCtD
Nebivolol—CYP2D6—Methamphetamine—obesity	0.0162	0.0739	CbGbCtD
Nebivolol—CYP2D6—Cimetidine—obesity	0.0126	0.0577	CbGbCtD
Nebivolol—Allergic cutaneous angiitis—Cimetidine—obesity	0.00293	0.0554	CcSEcCtD
Nebivolol—Leukocytoclastic vasculitis—Cimetidine—obesity	0.0019	0.0359	CcSEcCtD
Nebivolol—Atrioventricular block—Cimetidine—obesity	0.000961	0.0182	CcSEcCtD
Nebivolol—Erectile dysfunction—Methamphetamine—obesity	0.000906	0.0171	CcSEcCtD
Nebivolol—Psoriasis—Sibutramine—obesity	0.000792	0.015	CcSEcCtD
Nebivolol—Erectile dysfunction—Phentermine—obesity	0.000651	0.0123	CcSEcCtD
Nebivolol—Acute coronary syndrome—Phentermine—obesity	0.000621	0.0117	CcSEcCtD
Nebivolol—Myocardial infarction—Phentermine—obesity	0.000617	0.0117	CcSEcCtD
Nebivolol—Erectile dysfunction—Diethylpropion—obesity	0.000566	0.0107	CcSEcCtD
Nebivolol—Erectile dysfunction—Cimetidine—obesity	0.000539	0.0102	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Sibutramine—obesity	0.000526	0.00996	CcSEcCtD
Nebivolol—Insomnia—Methamphetamine—obesity	0.000506	0.00956	CcSEcCtD
Nebivolol—Insomnia—Benzphetamine—obesity	0.000488	0.00922	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Methamphetamine—obesity	0.000483	0.00913	CcSEcCtD
Nebivolol—Bradycardia—Cimetidine—obesity	0.000476	0.00901	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Benzphetamine—obesity	0.000465	0.0088	CcSEcCtD
Nebivolol—Hypercholesterolaemia—Bupropion—obesity	0.000459	0.00868	CcSEcCtD
Nebivolol—Insomnia—Phendimetrazine—obesity	0.000444	0.00841	CcSEcCtD
Nebivolol—Urticaria—Methamphetamine—obesity	0.000444	0.0084	CcSEcCtD
Nebivolol—Urticaria—Benzphetamine—obesity	0.000428	0.0081	CcSEcCtD
Nebivolol—Chest pain—Phentermine—obesity	0.000419	0.00793	CcSEcCtD
Nebivolol—Hypersensitivity—Methamphetamine—obesity	0.000412	0.00779	CcSEcCtD
Nebivolol—Hypersensitivity—Benzphetamine—obesity	0.000397	0.00751	CcSEcCtD
Nebivolol—Abdominal pain—Phendimetrazine—obesity	0.000388	0.00735	CcSEcCtD
Nebivolol—Diarrhoea—Methamphetamine—obesity	0.000383	0.00724	CcSEcCtD
Nebivolol—Insomnia—Phenylpropanolamine—obesity	0.00038	0.00718	CcSEcCtD
Nebivolol—Dyspnoea—Phenylpropanolamine—obesity	0.000374	0.00708	CcSEcCtD
Nebivolol—Somnolence—Phenylpropanolamine—obesity	0.000373	0.00706	CcSEcCtD
Nebivolol—Dizziness—Methamphetamine—obesity	0.00037	0.00699	CcSEcCtD
Nebivolol—Diarrhoea—Benzphetamine—obesity	0.000369	0.00698	CcSEcCtD
Nebivolol—Chest pain—Diethylpropion—obesity	0.000365	0.00689	CcSEcCtD
Nebivolol—Insomnia—Phentermine—obesity	0.000363	0.00687	CcSEcCtD
Nebivolol—Dizziness—Benzphetamine—obesity	0.000357	0.00674	CcSEcCtD
Nebivolol—Headache—Methamphetamine—obesity	0.00035	0.00662	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Phentermine—obesity	0.000347	0.00656	CcSEcCtD
Nebivolol—Fatigue—Phentermine—obesity	0.000346	0.00655	CcSEcCtD
Nebivolol—Headache—Benzphetamine—obesity	0.000338	0.00639	CcSEcCtD
Nebivolol—Diarrhoea—Phendimetrazine—obesity	0.000336	0.00636	CcSEcCtD
Nebivolol—Thrombocytopenia—Cimetidine—obesity	0.000326	0.00616	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Sibutramine—obesity	0.000325	0.00616	CcSEcCtD
Nebivolol—Dizziness—Phendimetrazine—obesity	0.000325	0.00615	CcSEcCtD
Nebivolol—Nausea—Benzphetamine—obesity	0.00032	0.00606	CcSEcCtD
Nebivolol—Urticaria—Phentermine—obesity	0.000319	0.00604	CcSEcCtD
Nebivolol—Abdominal pain—Phentermine—obesity	0.000318	0.00601	CcSEcCtD
Nebivolol—Bronchospasm—Orlistat—obesity	0.000318	0.00601	CcSEcCtD
Nebivolol—Insomnia—Diethylpropion—obesity	0.000316	0.00598	CcSEcCtD
Nebivolol—Dyspnoea—Diethylpropion—obesity	0.000312	0.00589	CcSEcCtD
Nebivolol—Somnolence—Diethylpropion—obesity	0.000311	0.00588	CcSEcCtD
Nebivolol—Hypersensitivity—Phenylpropanolamine—obesity	0.000309	0.00585	CcSEcCtD
Nebivolol—Headache—Phendimetrazine—obesity	0.000308	0.00582	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Diethylpropion—obesity	0.000302	0.00571	CcSEcCtD
Nebivolol—Somnolence—Cimetidine—obesity	0.000296	0.00559	CcSEcCtD
Nebivolol—Nausea—Phendimetrazine—obesity	0.000292	0.00552	CcSEcCtD
Nebivolol—Asthenia—Phentermine—obesity	0.000288	0.00545	CcSEcCtD
Nebivolol—Erectile dysfunction—Sibutramine—obesity	0.000288	0.00544	CcSEcCtD
Nebivolol—Fatigue—Cimetidine—obesity	0.000287	0.00542	CcSEcCtD
Nebivolol—Atrioventricular block—Topiramate—obesity	0.000285	0.00539	CcSEcCtD
Nebivolol—Urticaria—Diethylpropion—obesity	0.000278	0.00525	CcSEcCtD
Nebivolol—Dizziness—Phenylpropanolamine—obesity	0.000278	0.00525	CcSEcCtD
Nebivolol—Diarrhoea—Phentermine—obesity	0.000275	0.0052	CcSEcCtD
Nebivolol—Acute coronary syndrome—Sibutramine—obesity	0.000275	0.00519	CcSEcCtD
Nebivolol—Myocardial infarction—Sibutramine—obesity	0.000273	0.00516	CcSEcCtD
Nebivolol—Bronchospasm—Bupropion—obesity	0.000268	0.00507	CcSEcCtD
Nebivolol—Vomiting—Phenylpropanolamine—obesity	0.000267	0.00505	CcSEcCtD
Nebivolol—Dizziness—Phentermine—obesity	0.000266	0.00502	CcSEcCtD
Nebivolol—Rash—Phenylpropanolamine—obesity	0.000265	0.00501	CcSEcCtD
Nebivolol—Dermatitis—Phenylpropanolamine—obesity	0.000264	0.005	CcSEcCtD
Nebivolol—Vomiting—Phentermine—obesity	0.000255	0.00483	CcSEcCtD
Nebivolol—Bradycardia—Sibutramine—obesity	0.000255	0.00481	CcSEcCtD
Nebivolol—Oedema peripheral—Orlistat—obesity	0.000255	0.00481	CcSEcCtD
Nebivolol—Rash—Phentermine—obesity	0.000253	0.00479	CcSEcCtD
Nebivolol—Dermatitis—Phentermine—obesity	0.000253	0.00479	CcSEcCtD
Nebivolol—Headache—Phentermine—obesity	0.000252	0.00476	CcSEcCtD
Nebivolol—Erectile dysfunction—Bupropion—obesity	0.000251	0.00474	CcSEcCtD
Nebivolol—Nausea—Phenylpropanolamine—obesity	0.000249	0.00472	CcSEcCtD
Nebivolol—Oedema peripheral—Sibutramine—obesity	0.000246	0.00466	CcSEcCtD
Nebivolol—Hypersensitivity—Cimetidine—obesity	0.000245	0.00463	CcSEcCtD
Nebivolol—Acute coronary syndrome—Bupropion—obesity	0.000239	0.00453	CcSEcCtD
Nebivolol—Diarrhoea—Diethylpropion—obesity	0.000239	0.00452	CcSEcCtD
Nebivolol—Nausea—Phentermine—obesity	0.000239	0.00451	CcSEcCtD
Nebivolol—Asthenia—Cimetidine—obesity	0.000239	0.00451	CcSEcCtD
Nebivolol—Myocardial infarction—Bupropion—obesity	0.000238	0.0045	CcSEcCtD
Nebivolol—Dizziness—Diethylpropion—obesity	0.000231	0.00437	CcSEcCtD
Nebivolol—Diarrhoea—Cimetidine—obesity	0.000227	0.0043	CcSEcCtD
Nebivolol—Mental disorder—Orlistat—obesity	0.000226	0.00428	CcSEcCtD
Nebivolol—Malnutrition—Orlistat—obesity	0.000225	0.00425	CcSEcCtD
Nebivolol—Vomiting—Diethylpropion—obesity	0.000222	0.0042	CcSEcCtD
Nebivolol—Rash—Diethylpropion—obesity	0.00022	0.00417	CcSEcCtD
Nebivolol—Dermatitis—Diethylpropion—obesity	0.00022	0.00416	CcSEcCtD
Nebivolol—Dizziness—Cimetidine—obesity	0.00022	0.00416	CcSEcCtD
Nebivolol—Headache—Diethylpropion—obesity	0.000219	0.00414	CcSEcCtD
Nebivolol—Malnutrition—Sibutramine—obesity	0.000218	0.00412	CcSEcCtD
Nebivolol—Oedema peripheral—Bupropion—obesity	0.000215	0.00406	CcSEcCtD
Nebivolol—Vomiting—Cimetidine—obesity	0.000211	0.004	CcSEcCtD
Nebivolol—Rash—Cimetidine—obesity	0.00021	0.00397	CcSEcCtD
Nebivolol—Dermatitis—Cimetidine—obesity	0.000209	0.00396	CcSEcCtD
Nebivolol—Headache—Cimetidine—obesity	0.000208	0.00394	CcSEcCtD
Nebivolol—Nausea—Diethylpropion—obesity	0.000208	0.00393	CcSEcCtD
Nebivolol—Angioedema—Orlistat—obesity	0.000206	0.00389	CcSEcCtD
Nebivolol—Cardiac disorder—Bupropion—obesity	0.000202	0.00383	CcSEcCtD
Nebivolol—Vertigo—Orlistat—obesity	0.000202	0.00382	CcSEcCtD
Nebivolol—Angioedema—Sibutramine—obesity	0.000199	0.00376	CcSEcCtD
Nebivolol—Nausea—Cimetidine—obesity	0.000197	0.00374	CcSEcCtD
Nebivolol—Vertigo—Sibutramine—obesity	0.000196	0.0037	CcSEcCtD
Nebivolol—Syncope—Sibutramine—obesity	0.000195	0.00369	CcSEcCtD
Nebivolol—Chest pain—Orlistat—obesity	0.000191	0.00362	CcSEcCtD
Nebivolol—Loss of consciousness—Sibutramine—obesity	0.000191	0.00362	CcSEcCtD
Nebivolol—Mental disorder—Bupropion—obesity	0.000191	0.00361	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00019	0.0036	CcSEcCtD
Nebivolol—Malnutrition—Bupropion—obesity	0.00019	0.00359	CcSEcCtD
Nebivolol—Chest pain—Sibutramine—obesity	0.000185	0.0035	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Topiramate—obesity	0.000181	0.00342	CcSEcCtD
Nebivolol—Nervous system disorder—Orlistat—obesity	0.00018	0.0034	CcSEcCtD
Nebivolol—Skin disorder—Orlistat—obesity	0.000178	0.00337	CcSEcCtD
Nebivolol—Shock—Sibutramine—obesity	0.000175	0.00331	CcSEcCtD
Nebivolol—Thrombocytopenia—Sibutramine—obesity	0.000174	0.00329	CcSEcCtD
Nebivolol—Angioedema—Bupropion—obesity	0.000173	0.00328	CcSEcCtD
Nebivolol—Skin disorder—Sibutramine—obesity	0.000173	0.00326	CcSEcCtD
Nebivolol—Vertigo—Bupropion—obesity	0.00017	0.00322	CcSEcCtD
Nebivolol—Syncope—Bupropion—obesity	0.00017	0.00322	CcSEcCtD
Nebivolol—Loss of consciousness—Bupropion—obesity	0.000167	0.00315	CcSEcCtD
Nebivolol—Insomnia—Orlistat—obesity	0.000166	0.00314	CcSEcCtD
Nebivolol—Paraesthesia—Orlistat—obesity	0.000165	0.00312	CcSEcCtD
Nebivolol—Chest pain—Bupropion—obesity	0.000162	0.00306	CcSEcCtD
Nebivolol—Insomnia—Sibutramine—obesity	0.000161	0.00304	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00016	0.00303	CcSEcCtD
Nebivolol—Erectile dysfunction—Topiramate—obesity	0.00016	0.00302	CcSEcCtD
Nebivolol—Paraesthesia—Sibutramine—obesity	0.00016	0.00302	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Orlistat—obesity	0.000158	0.003	CcSEcCtD
Nebivolol—Dyspnoea—Sibutramine—obesity	0.000158	0.003	CcSEcCtD
Nebivolol—Fatigue—Orlistat—obesity	0.000158	0.00299	CcSEcCtD
Nebivolol—Somnolence—Sibutramine—obesity	0.000158	0.00299	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Sibutramine—obesity	0.000153	0.0029	CcSEcCtD
Nebivolol—Shock—Bupropion—obesity	0.000152	0.00288	CcSEcCtD
Nebivolol—Nervous system disorder—Bupropion—obesity	0.000152	0.00287	CcSEcCtD
Nebivolol—Thrombocytopenia—Bupropion—obesity	0.000152	0.00287	CcSEcCtD
Nebivolol—Skin disorder—Bupropion—obesity	0.00015	0.00285	CcSEcCtD
Nebivolol—Gastrointestinal pain—Orlistat—obesity	0.00015	0.00284	CcSEcCtD
Nebivolol—Urticaria—Orlistat—obesity	0.000146	0.00276	CcSEcCtD
Nebivolol—Gastrointestinal pain—Sibutramine—obesity	0.000145	0.00275	CcSEcCtD
Nebivolol—Abdominal pain—Orlistat—obesity	0.000145	0.00274	CcSEcCtD
Nebivolol—Bradycardia—Topiramate—obesity	0.000141	0.00267	CcSEcCtD
Nebivolol—Urticaria—Sibutramine—obesity	0.000141	0.00267	CcSEcCtD
Nebivolol—Abdominal pain—Sibutramine—obesity	0.00014	0.00266	CcSEcCtD
Nebivolol—Insomnia—Bupropion—obesity	0.00014	0.00265	CcSEcCtD
Nebivolol—Paraesthesia—Bupropion—obesity	0.000139	0.00263	CcSEcCtD
Nebivolol—Dyspnoea—Bupropion—obesity	0.000138	0.00261	CcSEcCtD
Nebivolol—Somnolence—Bupropion—obesity	0.000138	0.0026	CcSEcCtD
Nebivolol—Oedema peripheral—Topiramate—obesity	0.000137	0.00259	CcSEcCtD
Nebivolol—Hypersensitivity—Orlistat—obesity	0.000135	0.00256	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Bupropion—obesity	0.000134	0.00253	CcSEcCtD
Nebivolol—Fatigue—Bupropion—obesity	0.000134	0.00253	CcSEcCtD
Nebivolol—Asthenia—Orlistat—obesity	0.000132	0.00249	CcSEcCtD
Nebivolol—Hypersensitivity—Sibutramine—obesity	0.000131	0.00248	CcSEcCtD
Nebivolol—Pruritus—Orlistat—obesity	0.00013	0.00246	CcSEcCtD
Nebivolol—Cardiac disorder—Topiramate—obesity	0.000129	0.00244	CcSEcCtD
Nebivolol—Asthenia—Sibutramine—obesity	0.000127	0.00241	CcSEcCtD
Nebivolol—Gastrointestinal pain—Bupropion—obesity	0.000127	0.0024	CcSEcCtD
Nebivolol—Pruritus—Sibutramine—obesity	0.000126	0.00238	CcSEcCtD
Nebivolol—Diarrhoea—Orlistat—obesity	0.000126	0.00238	CcSEcCtD
Nebivolol—Urticaria—Bupropion—obesity	0.000123	0.00233	CcSEcCtD
Nebivolol—Abdominal pain—Bupropion—obesity	0.000122	0.00232	CcSEcCtD
Nebivolol—Mental disorder—Topiramate—obesity	0.000122	0.0023	CcSEcCtD
Nebivolol—Diarrhoea—Sibutramine—obesity	0.000122	0.0023	CcSEcCtD
Nebivolol—Dizziness—Orlistat—obesity	0.000121	0.0023	CcSEcCtD
Nebivolol—Malnutrition—Topiramate—obesity	0.000121	0.00229	CcSEcCtD
Nebivolol—Dizziness—Sibutramine—obesity	0.000117	0.00222	CcSEcCtD
Nebivolol—Vomiting—Orlistat—obesity	0.000117	0.00221	CcSEcCtD
Nebivolol—Rash—Orlistat—obesity	0.000116	0.00219	CcSEcCtD
Nebivolol—Dermatitis—Orlistat—obesity	0.000116	0.00219	CcSEcCtD
Nebivolol—Headache—Orlistat—obesity	0.000115	0.00217	CcSEcCtD
Nebivolol—Hypersensitivity—Bupropion—obesity	0.000114	0.00216	CcSEcCtD
Nebivolol—Vomiting—Sibutramine—obesity	0.000113	0.00214	CcSEcCtD
Nebivolol—Rash—Sibutramine—obesity	0.000112	0.00212	CcSEcCtD
Nebivolol—Dermatitis—Sibutramine—obesity	0.000112	0.00212	CcSEcCtD
Nebivolol—Headache—Sibutramine—obesity	0.000111	0.0021	CcSEcCtD
Nebivolol—Asthenia—Bupropion—obesity	0.000111	0.0021	CcSEcCtD
Nebivolol—Pruritus—Bupropion—obesity	0.00011	0.00207	CcSEcCtD
Nebivolol—Nausea—Orlistat—obesity	0.000109	0.00206	CcSEcCtD
Nebivolol—Vertigo—Topiramate—obesity	0.000109	0.00205	CcSEcCtD
Nebivolol—Syncope—Topiramate—obesity	0.000108	0.00205	CcSEcCtD
Nebivolol—Loss of consciousness—Topiramate—obesity	0.000106	0.00201	CcSEcCtD
Nebivolol—Diarrhoea—Bupropion—obesity	0.000106	0.002	CcSEcCtD
Nebivolol—Nausea—Sibutramine—obesity	0.000106	0.002	CcSEcCtD
Nebivolol—Chest pain—Topiramate—obesity	0.000103	0.00195	CcSEcCtD
Nebivolol—Dizziness—Bupropion—obesity	0.000102	0.00194	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000102	0.00193	CcSEcCtD
Nebivolol—Vomiting—Bupropion—obesity	9.85e-05	0.00186	CcSEcCtD
Nebivolol—Rash—Bupropion—obesity	9.77e-05	0.00185	CcSEcCtD
Nebivolol—Dermatitis—Bupropion—obesity	9.76e-05	0.00185	CcSEcCtD
Nebivolol—Shock—Topiramate—obesity	9.71e-05	0.00184	CcSEcCtD
Nebivolol—Headache—Bupropion—obesity	9.7e-05	0.00184	CcSEcCtD
Nebivolol—Nervous system disorder—Topiramate—obesity	9.68e-05	0.00183	CcSEcCtD
Nebivolol—Thrombocytopenia—Topiramate—obesity	9.66e-05	0.00183	CcSEcCtD
Nebivolol—Skin disorder—Topiramate—obesity	9.58e-05	0.00181	CcSEcCtD
Nebivolol—Nausea—Bupropion—obesity	9.2e-05	0.00174	CcSEcCtD
Nebivolol—Insomnia—Topiramate—obesity	8.92e-05	0.00169	CcSEcCtD
Nebivolol—Paraesthesia—Topiramate—obesity	8.86e-05	0.00168	CcSEcCtD
Nebivolol—Dyspnoea—Topiramate—obesity	8.8e-05	0.00166	CcSEcCtD
Nebivolol—Somnolence—Topiramate—obesity	8.77e-05	0.00166	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Topiramate—obesity	8.52e-05	0.00161	CcSEcCtD
Nebivolol—Fatigue—Topiramate—obesity	8.51e-05	0.00161	CcSEcCtD
Nebivolol—Gastrointestinal pain—Topiramate—obesity	8.07e-05	0.00153	CcSEcCtD
Nebivolol—Urticaria—Topiramate—obesity	7.84e-05	0.00148	CcSEcCtD
Nebivolol—Abdominal pain—Topiramate—obesity	7.8e-05	0.00148	CcSEcCtD
Nebivolol—Hypersensitivity—Topiramate—obesity	7.27e-05	0.00137	CcSEcCtD
Nebivolol—Asthenia—Topiramate—obesity	7.08e-05	0.00134	CcSEcCtD
Nebivolol—Pruritus—Topiramate—obesity	6.98e-05	0.00132	CcSEcCtD
Nebivolol—Diarrhoea—Topiramate—obesity	6.75e-05	0.00128	CcSEcCtD
Nebivolol—Dizziness—Topiramate—obesity	6.52e-05	0.00123	CcSEcCtD
Nebivolol—Vomiting—Topiramate—obesity	6.27e-05	0.00119	CcSEcCtD
Nebivolol—Rash—Topiramate—obesity	6.22e-05	0.00118	CcSEcCtD
Nebivolol—Dermatitis—Topiramate—obesity	6.22e-05	0.00118	CcSEcCtD
Nebivolol—Headache—Topiramate—obesity	6.18e-05	0.00117	CcSEcCtD
Nebivolol—Nausea—Topiramate—obesity	5.86e-05	0.00111	CcSEcCtD
Nebivolol—ADRB2—Signaling Pathways—STK11—obesity	5.15e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT2—obesity	5.14e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3R1—obesity	5.14e-06	0.000123	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—CCL2—obesity	5.12e-06	0.000123	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—POMC—obesity	5.12e-06	0.000123	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRL—obesity	5.11e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PLG—obesity	5.09e-06	0.000122	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA5—obesity	5.09e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—RHOA—obesity	5.08e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FOXO3—obesity	5.08e-06	0.000122	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ADRB2—obesity	5.06e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT2—obesity	5.03e-06	0.000121	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STK11—obesity	5.03e-06	0.000121	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3R1—obesity	5.03e-06	0.00012	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—CCL2—obesity	5.01e-06	0.00012	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS1—obesity	4.99e-06	0.00012	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PLG—obesity	4.98e-06	0.000119	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—RHOA—obesity	4.97e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FOXO3—obesity	4.97e-06	0.000119	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CD—obesity	4.94e-06	0.000118	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SOCS3—obesity	4.93e-06	0.000118	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT2—obesity	4.92e-06	0.000118	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3R1—obesity	4.92e-06	0.000118	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS1—obesity	4.88e-06	0.000117	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FOXO3—obesity	4.86e-06	0.000116	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC22A1—obesity	4.85e-06	0.000116	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CLOCK—obesity	4.85e-06	0.000116	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ADRB2—obesity	4.84e-06	0.000116	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CD—obesity	4.84e-06	0.000116	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GNB3—obesity	4.82e-06	0.000116	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SOCS3—obesity	4.82e-06	0.000115	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS1—obesity	4.77e-06	0.000114	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—TYK2—obesity	4.76e-06	0.000114	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CB—obesity	4.74e-06	0.000114	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF2—obesity	4.74e-06	0.000114	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SULT2A1—obesity	4.73e-06	0.000113	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GLP1R—obesity	4.73e-06	0.000113	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CD—obesity	4.73e-06	0.000113	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GNB3—obesity	4.72e-06	0.000113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—RHOA—obesity	4.72e-06	0.000113	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SOCS3—obesity	4.71e-06	0.000113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—GNAS—obesity	4.7e-06	0.000113	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3R1—obesity	4.67e-06	0.000112	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DPYD—obesity	4.65e-06	0.000112	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—TYK2—obesity	4.65e-06	0.000111	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CB—obesity	4.64e-06	0.000111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF2—obesity	4.63e-06	0.000111	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—RHOA—obesity	4.61e-06	0.000111	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GNB3—obesity	4.61e-06	0.000111	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOB—obesity	4.6e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—GNAS—obesity	4.59e-06	0.00011	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3R1—obesity	4.57e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—TYK2—obesity	4.55e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CB—obesity	4.54e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF2—obesity	4.53e-06	0.000109	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—RHOA—obesity	4.51e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOB—obesity	4.5e-06	0.000108	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—GNAS—obesity	4.49e-06	0.000108	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL5—obesity	4.49e-06	0.000108	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PRKAR2B—obesity	4.48e-06	0.000107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3R1—obesity	4.46e-06	0.000107	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—DCN—obesity	4.45e-06	0.000107	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOB—obesity	4.4e-06	0.000105	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL5—obesity	4.39e-06	0.000105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LPL—obesity	4.39e-06	0.000105	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—FOXO1—obesity	4.36e-06	0.000104	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RPS6KB1—obesity	4.35e-06	0.000104	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CPT1A—obesity	4.33e-06	0.000104	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CB—obesity	4.31e-06	0.000103	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL5—obesity	4.3e-06	0.000103	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LPL—obesity	4.3e-06	0.000103	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—FOXO1—obesity	4.26e-06	0.000102	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RPS6KB1—obesity	4.26e-06	0.000102	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NAMPT—obesity	4.24e-06	0.000102	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCK—obesity	4.22e-06	0.000101	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LIPC—obesity	4.22e-06	0.000101	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CB—obesity	4.21e-06	0.000101	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LPL—obesity	4.2e-06	0.000101	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOC3—obesity	4.19e-06	0.0001	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—FOXO1—obesity	4.17e-06	9.99e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RPS6KB1—obesity	4.16e-06	9.97e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CB—obesity	4.12e-06	9.88e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CETP—obesity	4.07e-06	9.75e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCD—obesity	4.05e-06	9.69e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SDC1—obesity	4.02e-06	9.64e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—HTR2A—obesity	3.96e-06	9.49e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCD—obesity	3.96e-06	9.48e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKR1C3—obesity	3.96e-06	9.48e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—C3—obesity	3.95e-06	9.47e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SCARB1—obesity	3.89e-06	9.33e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—HTR2A—obesity	3.87e-06	9.28e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCD—obesity	3.87e-06	9.27e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—C3—obesity	3.87e-06	9.27e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—HTR2A—obesity	3.79e-06	9.07e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—C3—obesity	3.78e-06	9.06e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SREBF1—obesity	3.78e-06	9.06e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IRS2—obesity	3.76e-06	9.01e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AGT—obesity	3.76e-06	9e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOE—obesity	3.68e-06	8.82e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—LEP—obesity	3.68e-06	8.82e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IRS2—obesity	3.68e-06	8.82e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GOT2—obesity	3.68e-06	8.81e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AGT—obesity	3.67e-06	8.81e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CAV1—obesity	3.65e-06	8.74e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—APOA1—obesity	3.64e-06	8.72e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—LEP—obesity	3.6e-06	8.63e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOE—obesity	3.6e-06	8.63e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—FASN—obesity	3.6e-06	8.63e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IRS2—obesity	3.6e-06	8.62e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AGT—obesity	3.59e-06	8.61e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—BCHE—obesity	3.58e-06	8.59e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CAV1—obesity	3.57e-06	8.55e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—APOA1—obesity	3.56e-06	8.53e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—LEP—obesity	3.52e-06	8.44e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOE—obesity	3.52e-06	8.44e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—ESR1—obesity	3.51e-06	8.42e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CAV1—obesity	3.49e-06	8.36e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—APOA1—obesity	3.48e-06	8.34e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PRKCB—obesity	3.47e-06	8.32e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—F2—obesity	3.47e-06	8.32e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP2E1—obesity	3.46e-06	8.29e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—ESR1—obesity	3.44e-06	8.24e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—BAD—obesity	3.43e-06	8.22e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NQO1—obesity	3.42e-06	8.19e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PRKCB—obesity	3.4e-06	8.14e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—F2—obesity	3.4e-06	8.14e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—ESR1—obesity	3.36e-06	8.05e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—BAD—obesity	3.35e-06	8.04e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CG—obesity	3.32e-06	7.96e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PRKCB—obesity	3.32e-06	7.96e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—F2—obesity	3.32e-06	7.96e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IRS1—obesity	3.28e-06	7.87e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—BAD—obesity	3.28e-06	7.86e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—SLC2A4—obesity	3.28e-06	7.86e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GCG—obesity	3.28e-06	7.86e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CG—obesity	3.25e-06	7.79e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYCS—obesity	3.24e-06	7.75e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IRS1—obesity	3.21e-06	7.7e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CG—obesity	3.18e-06	7.61e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GGT1—obesity	3.17e-06	7.61e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GOT1—obesity	3.17e-06	7.61e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—POMC—obesity	3.16e-06	7.58e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—INS—obesity	3.14e-06	7.53e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IRS1—obesity	3.14e-06	7.53e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NCOA1—obesity	3.13e-06	7.49e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—CCL2—obesity	3.09e-06	7.41e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—POMC—obesity	3.09e-06	7.41e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—STK11—obesity	3.08e-06	7.39e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CYP19A1—obesity	3.08e-06	7.39e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—INS—obesity	3.08e-06	7.37e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IGF1—obesity	3.04e-06	7.29e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT2—obesity	3.04e-06	7.28e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—CCL2—obesity	3.03e-06	7.25e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—POMC—obesity	3.02e-06	7.25e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—INS—obesity	3.01e-06	7.21e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IGF1—obesity	2.98e-06	7.13e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT2—obesity	2.97e-06	7.12e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—CCL2—obesity	2.96e-06	7.09e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CD—obesity	2.92e-06	7e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IGF1—obesity	2.91e-06	6.97e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT2—obesity	2.91e-06	6.97e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—PIK3CA—obesity	2.89e-06	6.93e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—SERPINE1—obesity	2.89e-06	6.92e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—COMT—obesity	2.87e-06	6.87e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CD—obesity	2.86e-06	6.85e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—PIK3CA—obesity	2.83e-06	6.78e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARGC1A—obesity	2.83e-06	6.77e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNB3—obesity	2.83e-06	6.77e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—SERPINE1—obesity	2.83e-06	6.77e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—HMOX1—obesity	2.81e-06	6.74e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TYK2—obesity	2.81e-06	6.73e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CD—obesity	2.79e-06	6.69e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—RHOA—obesity	2.79e-06	6.68e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—PIK3CA—obesity	2.77e-06	6.63e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—SERPINE1—obesity	2.76e-06	6.62e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3R1—obesity	2.76e-06	6.61e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—NOS3—obesity	2.76e-06	6.61e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GNAS—obesity	2.75e-06	6.59e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TYK2—obesity	2.75e-06	6.59e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—RHOA—obesity	2.73e-06	6.53e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3R1—obesity	2.7e-06	6.46e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—NOS3—obesity	2.7e-06	6.46e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOB—obesity	2.69e-06	6.46e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TYK2—obesity	2.69e-06	6.44e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—RHOA—obesity	2.66e-06	6.39e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3R1—obesity	2.64e-06	6.32e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—NOS3—obesity	2.64e-06	6.32e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—PIK3CA—obesity	2.63e-06	6.29e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—LPL—obesity	2.57e-06	6.16e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—PIK3CA—obesity	2.57e-06	6.16e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MTOR—obesity	2.55e-06	6.1e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CB—obesity	2.55e-06	6.1e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—PIK3CA—obesity	2.51e-06	6.02e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—GPX1—obesity	2.51e-06	6.01e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CB—obesity	2.49e-06	5.97e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MTOR—obesity	2.49e-06	5.97e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CD36—obesity	2.44e-06	5.86e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CB—obesity	2.43e-06	5.83e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MTOR—obesity	2.43e-06	5.83e-05	CbGpPWpGaD
Nebivolol—ADRB1—GPCR downstream signaling—AKT1—obesity	2.36e-06	5.66e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—IL6—obesity	2.33e-06	5.57e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—MTHFR—obesity	2.32e-06	5.55e-05	CbGpPWpGaD
Nebivolol—ADRB2—GPCR downstream signaling—AKT1—obesity	2.31e-06	5.54e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—IL6—obesity	2.28e-06	5.45e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARA—obesity	2.27e-06	5.45e-05	CbGpPWpGaD
Nebivolol—HTR1A—GPCR downstream signaling—AKT1—obesity	2.26e-06	5.42e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—IL6—obesity	2.22e-06	5.33e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MMP9—obesity	2.21e-06	5.3e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AGT—obesity	2.2e-06	5.27e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MMP9—obesity	2.16e-06	5.19e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOE—obesity	2.16e-06	5.17e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MAPK8—obesity	2.15e-06	5.16e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling by GPCR—AKT1—obesity	2.15e-06	5.14e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—CAV1—obesity	2.14e-06	5.12e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—APOA1—obesity	2.13e-06	5.11e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MMP9—obesity	2.12e-06	5.07e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MAPK8—obesity	2.1e-06	5.04e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling by GPCR—AKT1—obesity	2.1e-06	5.03e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MAPK8—obesity	2.06e-06	4.93e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling by GPCR—AKT1—obesity	2.05e-06	4.92e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—STAT3—obesity	1.97e-06	4.71e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CG—obesity	1.95e-06	4.66e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—STAT3—obesity	1.92e-06	4.61e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—STAT3—obesity	1.88e-06	4.51e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PPARG—obesity	1.88e-06	4.5e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—POMC—obesity	1.85e-06	4.44e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—INS—obesity	1.84e-06	4.41e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—MYC—obesity	1.83e-06	4.38e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—TGFB1—obesity	1.82e-06	4.37e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—MYC—obesity	1.79e-06	4.28e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—TGFB1—obesity	1.78e-06	4.27e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—MYC—obesity	1.75e-06	4.19e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—TGFB1—obesity	1.74e-06	4.18e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CD—obesity	1.71e-06	4.1e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—ALB—obesity	1.69e-06	4.05e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—NOS3—obesity	1.62e-06	3.87e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3R1—obesity	1.62e-06	3.87e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—PIK3CA—obesity	1.55e-06	3.72e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—PIK3CA—obesity	1.52e-06	3.64e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CB—obesity	1.49e-06	3.57e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—PIK3CA—obesity	1.48e-06	3.56e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PTGS2—obesity	1.48e-06	3.54e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—IL6—obesity	1.37e-06	3.29e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—IL6—obesity	1.34e-06	3.22e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—IL6—obesity	1.31e-06	3.15e-05	CbGpPWpGaD
Nebivolol—ADRB1—Signaling Pathways—AKT1—obesity	1.27e-06	3.04e-05	CbGpPWpGaD
Nebivolol—ADRB2—Signaling Pathways—AKT1—obesity	1.24e-06	2.97e-05	CbGpPWpGaD
Nebivolol—HTR1A—Signaling Pathways—AKT1—obesity	1.21e-06	2.91e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—PIK3CA—obesity	9.09e-07	2.18e-05	CbGpPWpGaD
Nebivolol—CYP2D6—Metabolism—AKT1—obesity	7.43e-07	1.78e-05	CbGpPWpGaD
